Integrated evidence chain (Eff-iEC) based effectiveness evaluation of a multifunctional traditional Chinese medicine formula: Taking Xiaoyao San as an example
10.1097/st9.0000000000000104
- Author:
Caiping HE
1
;
Ye LUO
2
;
Zhiqi LI
3
;
Haocheng YANG
4
;
Lu LIU
3
;
Yingjie XU
3
;
Xiaoyan CHEN
3
;
Siqi HUANG
3
;
Jincai WEN
3
;
Xiaoyan ZHAN
3
;
Zhaofang BAI
3
;
Xu ZHAO
3
;
Xiaohe XIAO
3
Author Information
1. School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China; The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China; Department of Hepatology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
2. Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
3. The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China; Department of Hepatology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
4. School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China
- Publication Type:Journal Article
- Keywords:
GRADE;
Integrated evidence chain;
TCM effectiveness evaluation;
Xiaoyao San
- From:
Science of Traditional Chinese Medicine
2026;4(1):96-103
- CountryChina
- Language:English
-
Abstract:
The study focuses on the concept of multifunctional traditional Chinese medicine (TCM) formulas and aims to evaluate the efficacy of the classical formula Xiaoyao San (逍遥散). Study employs the integrated evidence chain (Eff-iEC) method to organize, integrate, and evaluate its therapeutic efficacy in treating different diseases with the same therapy, and to investigate the feasibility of using Eff-iEC to evaluate the multifunctionality of TCM formulas. The evaluation covered Xiaoyao San's therapeutic effects on depression, premenstrual syndrome, chronic hepatitis, irritable bowel syndrome, dyspepsia, and menopausal syndrome. Concurrently, the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system was used for evaluation, and authoritative medical documents were incorporated to corroborate the recognition of Xiaoyao San within the medical community. Depression and menopausal syndrome received higher ratings than other conditions in the Eff-iEC, GRADE, and Medical Community Recognition assessments. The Eff-iEC evidence grade for Xiaoyao San was rated as "High" or above for chronic hepatitis, irritable bowel syndrome, dyspepsia, and menopausal syndrome. Premenstrual syndrome received a "Moderate +" rating. The GRADE evidence level was "Low-〇〇⨁⨁" for depression, premenstrual syndrome, and chronic hepatitis; "Moderate-〇⨁⨁⨁" for dyspepsia and menopausal syndrome; and "Very Low-〇〇〇⨁" for irritable bowel syndrome. Depression and menopausal syndrome had the highest inclusion frequency, appearing in all 4 categories. Premenstrual syndrome, chronic hepatitis, and dyspepsia are not recommended in Western medical guidelines, but they are included in TCM guidelines, the China National Basic Medical Insurance Drug List, and the China National Essential Drug List. Irritable bowel syndrome appears only in the China National Basic Medical Insurance Drug List and China National Essential Drug List. The evaluation results obtained using the Eff-iEC method align with Medical Community Recognition, providing an objective and comprehensive assessment of Xiaoyao San's efficacy. The findings suggest that Xiaoyao San has strong evidence for treating depression and menopausal syndrome. However, further experimental and clinical trials are needed to assess its efficacy in treating premenstrual syndrome, chronic hepatitis, irritable bowel syndrome, and dyspepsia. These results support the clinical efficacy and rational use of Xiaoyao San, expand the application scope of the Eff-iEC method, and offer valuable insights and methodological references for the comparative evaluation of multifunctional TCM formulas.
